Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06385171 · ClinicalTrials.gov registry record
Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical Investigation
A clinical trial of Wrinkle, sponsored by Global Aesthetics.
- Recruiting
- Registry status
- 500
- Enrollment target
- 2
- Study locations
NCT06385171: Recruiting study of Wrinkle, sponsored by Global Aesthetics.
NCT06385171 is a study of Wrinkle that is actively recruiting participants, run by Global Aesthetics. The registered enrollment target is 500 participants, above the 100-participant average among 25 other Wrinkle trials with a reported enrollment target (400% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06385171, a study of Wrinkle, is actively recruiting participants, sponsored by Global Aesthetics.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 2
- Study locations
Study Summary
A study conducting to see how well a treatment called Botulinum Toxin Type A works for reducing facial wrinkles. The study will help us understand if this treatment is safe and effective for making wrinkles on the face less noticeable.
Conditions Studied
Interventions
- DRUG Botulinum toxin type A
Study Locations (2)
Texas
- Global Aesthetics LLC - Cisco
- Global Aesthetics LLC - Lubbock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2024-05-22 |
| Est. Completion | 2027-01-05 |
What NCT06385171 shows while recruiting
NCT06385171 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 100-participant average among 25 other Wrinkle trials with a reported enrollment target (400% higher).
The record links to 1 condition, with Wrinkle appearing as the primary indexed condition, and to 1 intervention - of which Botulinum toxin type A is the first listed.
NCT06385171 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06385171 about?
NCT06385171 is a clinical study titled "Assessing the Impact of Botulinum Toxin Type A on Facial Wrinkles: A Comprehensive Clinical Investigation". A study conducting to see how well a treatment called Botulinum Toxin Type A works for reducing facial wrinkles. The study will help us understand if this treatment is safe and effective for making wrinkles on the face less noticeable.
What is the current status of trial NCT06385171?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2024-05-22. Estimated completion is 2027-01-05.
What conditions does trial NCT06385171 study?
This clinical trial studies the following conditions: Wrinkle.
What interventions are being tested in trial NCT06385171?
The interventions under investigation include: Botulinum toxin type A (DRUG).
Who is sponsoring clinical trial NCT06385171?
This trial is sponsored by Global Aesthetics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06385171 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wrinkle
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06385171's enrollment target sits among peer trials
500 1st of 25 higher than 23 of 25 other Wrinkle trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Wrinkle trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effects of Topical Almond Oil and Tretinoin on Facial Wrinkles
RECRUITING · NA
-
AVAVA MIRIA General Use
RECRUITING · NA
-
Feasibility Study to Collect and Assess Safety Data for a Radiofrequency Microneedling Device for Electrocoagulation and Hemostasis of Soft Tissues for Dermatologic Conditions
RECRUITING · NA
-
The Effects of Almond on Facial Skin Collagen and Wrinkles
RECRUITING · NA
-
A Prospective Controlled Study to Evaluate the Safety and Effectiveness of Thermage® FLX Radiofrequency Treatment
RECRUITING · NA
-
A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) for the Treatment of Superficial Skin Depressions
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI